SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193805-23-001628
Filing Date
2023-12-19
Accepted
2023-12-19 20:01:03
Documents
1
Period of Report
2023-12-15

Document Format Files

Seq Description Document Type Size
1 e619135_4-kurata.html 4  
1 e619135_4-kurata.xml 4 4352
  Complete submission text file 0001193805-23-001628.txt   5816
Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121 8589002660
Arcturus Therapeutics Holdings Inc. (Issuer) CIK: 0001768224 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121
Business Address
Kurata Lance (Reporting) CIK: 0001820961 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38942 | Film No.: 231499060